Literature DB >> 7007194

Insulin resistance in liver cirrhosis: decreased insulin binding to circulating monocytes.

A V Greco, A Bertoli, G Ghirlanda, R Manna, L Altomonte, A G Rebuzzi.   

Abstract

Hyperinsulinemia and insulin resistance have been reported in patients with liver cirrhosis. Since insulin receptor decrease has been demonstrated in some conditions of insulin resistance, we have studied insulin binding to circulating monocytes in eleven patients with alcoholic liver cirrhosis. Specific insulin binding at tracer concentration was lower in cirrhotics than in control subjects (p < 0.005). Insulin binding to monocytes was correlated with basal plasma insulin level in cirrhotics (r = -0.76; p < 0.01). The inhibiting effect of native insulin on 125I-insulin binding was similar in cirrhotics and controls suggesting that concentration rather than affinity of the binding sites is affected in cirrhosis of the liver. These findings suggest that decrease in insulin receptor concentration exists in liver cirrhosis, probably as a consequence of chronic hyperinsulinemia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7007194     DOI: 10.1055/s-2007-999204

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  10 in total

Review 1.  Insulin receptors and the clinician.

Authors:  R Taylor
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-05

2.  Insulin resistance in porphyria cutanea tarda.

Authors:  F Calcinaro; G Basta; P Lisi; C Cruciani; M Pietropaolo; F Santeusanio; A Falorni; R Calafiore
Journal:  J Endocrinol Invest       Date:  1989-06       Impact factor: 4.256

3.  Insulin binding to erythrocytes in hyperinsulinemic patients with precirrhotic hemochromatosis and cirrhosis.

Authors:  A S Petrides; W Passlack; H Reinauer; W Stremmel; G Strohmeyer
Journal:  Klin Wochenschr       Date:  1987-09-15

4.  Hepatic kinome atlas: An in-depth identification of kinase pathways in liver fibrosis of humans and rodents.

Authors:  Justin F Creeden; Zachary A Kipp; Mei Xu; Robert M Flight; Hunter N B Moseley; Genesee J Martinez; Wang-Hsin Lee; Khaled Alganem; Ali S Imami; Megan R McMullen; Sanjoy Roychowdhury; Atta M Nawabi; Jennifer A Hipp; Samir Softic; Steven A Weinman; Robert McCullumsmith; Laura E Nagy; Terry D Hinds
Journal:  Hepatology       Date:  2022-04-08       Impact factor: 17.298

5.  In vivo insulin action in hepatocellular and cholestatic liver cirrhosis.

Authors:  N Barzilai; P Cohen; E Karnieli; R Enat; O Epstein; J Owen; N McIntyre
Journal:  J Endocrinol Invest       Date:  1991-10       Impact factor: 4.256

6.  Insulin resistance is the main determinant of impaired glucose tolerance in patients with liver cirrhosis.

Authors:  G Marchesini; G P Bianchi; G Forlani; A G Rusticali; D Patrono; M Capelli; M Zoli; P Vannini; E Pisi
Journal:  Dig Dis Sci       Date:  1987-10       Impact factor: 3.199

7.  Changes in immunoreactive insulin, C-peptide immunoreactivity, and immunoreactive glucagon in acute viral hepatitis.

Authors:  K Kaneko; M Arai; H Funatomi; Y Hatta; K Mitamura
Journal:  J Gastroenterol       Date:  1995-10       Impact factor: 7.527

8.  Decreased insulin binding to red blood cells in liver cirrhosis.

Authors:  A V Greco; A Bentoli; S Caputo; L Altomonte; R Manna; G Ghirlanda
Journal:  Acta Diabetol Lat       Date:  1983 Jul-Sep

9.  Possible roles of insulin, glucagon, growth hormone and free fatty acids in the pathogenesis of insulin resistance of subjects with chronic liver diseases.

Authors:  E Bonora; S Orioli; C Coscelli; G Buzzelli; P Gentilini; U Butturini
Journal:  Acta Diabetol Lat       Date:  1984 Jul-Sep

Review 10.  Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways.

Authors:  Olufunto O Badmus; Sarah A Hillhouse; Christopher D Anderson; Terry D Hinds; David E Stec
Journal:  Clin Sci (Lond)       Date:  2022-09-30       Impact factor: 6.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.